Purdue’s Sacklers Said to Mull $1 Billion Opioid-Deal Boost (1)

Members of the billionaire Sackler family that own Purdue Pharma LP are weighing whether to add $1 billion to the OxyContin-maker’s faltering opioid settlement bid in an effort to win over holdouts, according to people familiar with the talks.

The move would bring the family’s total contribution to $5.325 billion to get a handful of state attorneys general to drop their opposition to Purdue’s bankruptcy plan, the people said. In return, the states would abandon appeals of the Sacklers’ demands to be freed from liability in current and future opioid lawsuits, the people added.

“This sounds like a good deal ...